DOCS Doximity, Inc.
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.…
Industry Peers
Health Information ServicesKey Statistics
About Doximity (NYSE: DOCS)
›
Doximity (NYSE: DOCS) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 880 employees.
The shares were at 28.73 USD on 20 November 2026, down 40.1% over 52 weeks. Its 52-week range is 17.15 USD to 51.85 USD: the price is 44.6% below the high and 67.5% above the low.
At a market capitalisation of 5.13B USD, it trades at 39.9 times trailing earnings and 18.5 times forward earnings. The median trailing P/E of its 15 largest Health Information Services peers is 43.6, so DOCS is valued in line with them.
Doximity reports return on equity of 20.6%, an operating margin of 27.1% and revenue up 3.6% year over year.
It holds more cash than debt, a net cash position of 704.08M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 18 analysts cover the stock, with an average rating of Hold; their mean price target of 31.50 USD is 9.6% above the current price. The next earnings report is expected on 4 February 2027.